R.5855 of 2025

Release: 106

G.G.52105 - 12 February 2025

Exemption of Manufacturers, Wholesalers and Distributors of Class A Medical Devices and In Vitro Diagnostics

R.5856 of 2025

Release: 106

G.G.52106 - 12 February 2025

Regulations regarding fees payable in terms of the Provisions of the Act

R.5731 of 2024

Release: 105

G.G.51820 - 27 December 2024

Annual Single Exit Price Adjustment of Medicines and Scheduled Substances

R.5732 of 2024

Release: 105

G.G.51821 - 23 December 2024

Exemption of Medical Devices and In-Vitro Diagnostics (IVDs)

R.5359 of 2024

Release: 104

G.G.51352 - 04 October 2024

Dispensing fee to be charged by persons licensed in terms of section 22C(1)(a)

R.5361 of 2024

Release: 104

G.G.51352 - 04 October 2024

Exclusive of medicines from the application of certain provisions

R.5364 of 2024

Release: 104

G.G.51352 - 04 October 2024

Amendment: Regulations relating to a transparent pricing system for medicines and scheduled substances: Dispensing fee for pharmacists

R.5181 of 2024

Release: 103

G.G.51171 - 06 September 2024

Schedules of various substances subject to particular conditions and inclusion of new chemical entities

R.4487 of 2024

Release: 102

G.G.50273 - 08 March 2024

SEPA of medicines and Scheduled substances for the year 2024

R.4406 of 2024

Release: 101

G.G.50164 - 23 February 2024

Exemption of manufacturers, wholesalers & distributors of Class A medical & in vitro diagnostics

R.3875 of 2023

Release: 100

G.G.49309 - 15 September 2023

Dispensing fee to be charged by persons licensed in terms of section 22C(1)(a)

R.3816 of 2023

Release: 99

G.G.49189 - 25 August 2023

Amendments to Dispensing fee for pharmacists

R.3800 of 2023

Release: 98

G.G.49140 - 18 August 2023

Exclusion of Schedule Zero (0) medicines from the operations of sections 22G and 18A of the Act

R.3801 of 2023

Release: 98

G.G.49140 - 18 August 2023

Second single exit price increase (SEPI) of Medicines and Schedule Substances for the year 2023 (Top-Up-SEPI)

R.3382 of 2023

Release: 97

G.G.48524 - 05 May 2023

Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions

R.3343 of 2023

Release: 96

G.G.48475 - 28 March 2023

General Regulations made in terms of the Act Amendment, 2023

R.2940 of 2023

Release: 95

G.G.47883 - 20 January 2023

Annual Single Exit Price Adjustment (SEPA) of Medicines and Scheduled Substances for the year 2023

R.2853 of 2022

Release: 94

G.G.47673 - 08 December 2022

General regulations made in terms of the Medicines and Related Substances Act: Amendment

R.2685 of 2022

Release: 93

G.G.47373 - 28 October 2022

South African Health Products Regulatory Authority (SAHPRA), made and updated the Schedules

R.2412 of 2022

Release: 92

G.G.46789 - 26 August 2022

Amend Schedules

R.2382 of 2022

Release: 91

G.G.46736 - 19 August 2022

Notification of registration of medicines in terms of section 17 of the Act

R.2342 of 2022

Release: 90

G.G.47197 - 05 August 2022

Annual Single Exit Price Adjustment (SEPA) of medicines & scheduled substances for the year 2023

R.2343 of 2022

Release: 90

G.G.47197 - 05 August 2022

Amendment to Dispensing fee to be charged by persons licensed in terms of section 22C(1)(a)

R.2266 of 2022

Release: 89

G.G.46688 - 08 July 2022

Regulations relating to a Transparent Pricing System for medicines and Scheduled substances: Dispensing Fee for Pharmacists

R.1722 of 2022

Release: 88

G.G.45859 - 04 February 2022

Guidelines to Annual Single Exit Price Adjustments (SEPA) of Medicines and Scheduled Substances for the year 2022

R.1632 of 2021

Release: 87

G.G.45673 - 17 December 2021

Extension Notice: Extension to the Exemption of Medical Devices & In-Vitro Diagnostics from the Provisions of Section 18A & Section 18B of the Act

R.1581 of 2021

Release: 86

G.G.45616 - 10 December 2021

Exclusion of Schedule 0 medicines from the operation of Sections 22G and 18A of the Act

R.1502 of 2021

Release: 85

G.G.45487 - 15 November 2021

Exclusion of COVID-19 vaccines from the operation of certain provisions of the Act

R.883 of 2021

Release: 84

G.G.45176 - 17 September 2021

Amendments to Schedules

R.756 of 2021

Release: 83

G.G.45057 - 27 August 2021

Exclusion of certain Alcohol-Based Hand-Rubs from the Operation of Specified Provisions of the Act

Notice 139 of 2021

Release: 82

G.G.44333 - 26 March 2021

Regulations relating to a transparent pricing system for medicines and scheduled substances

R.267 of 2021

Release: 82

G.G.44398 - 26 March 2021

Annual single price adjustment (SEPA) of medicines and scheduled substances for the year 2021

R.252 of 2021

Release: 81

G.G.44322 - 25 March 2021

Exclusion of Schedule 2, Schedule 3 and Schedule 4 from Certain Provisions of Medicines and Related Substances Act

R.1375 of 2020

Release: 80

G.G.44019 - 18 December 2020

Updates to Schedules

R.1379 of 2020

Release: 80

G.G.44026 - 22 December 2020

Regulations regarding fees payable in terms of the Act

R.1233 of 2020

Release: 79

G.G.43913 - 20 November 2020

Amendment of Government Notice 514: Exclusion of Schedule 2, Schedule 3 and Schedule 4 substances from the Operation of certain Provisions of the Act

R.721 of 2020

Release: 78

G.G.43484 - 26 June 2020

Exclusion of Certain Alcohol-Based Hand-Rubs from the Operation of Specified Provisions of the Act

R.679 of 2020

Release: 77

G.G.43447 - 19 June 2020

Amendment to Regulations Relating to Transparent Pricing System for Medicines and Schedules Substances: Dispensing Fee for Pharmacists

R.585 of 2020

Release: 76

G.G.43346 - 22 May 2020

Exclusion of Medicines, Medical Devices and In Vitro Diagnostics (IVDs) Donated to the State from the Operation of certain Provisions of the Act

R.586 of 2020

Release: 76

G.G.43347 - 22 May 2020

Amendment to Schedules

R.514 of 2020

Release: 75

G.G.43294 - 07 May 2020

Exclusion of Schedule 2, Schedule 3 and Schedule 4 Substances from the operation of certain Provisions of the Act

R.481 of 2020

Release: 74

G.G.43260 - 30 April 2020

Exclusion of Schedule 2, Schedule 3 and Schedule 4 Substances from the Operation of Certain Provisions of the Act

R.322 of 2020

Release: 73

G.G.43110 - 20 March 2020

Annual Single Exit Price Adjustment (SEPA) of Medicines and Scheduled Substances for the Year 2020.

R.377 of 2020

Release: 73

G.G.43145 - 27 March 2020

Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances [Dispensing Fee to be charged by Persons Licensed in terms of Section 22C (1)(a)]

R.219 of 2020

Release: 72

G.G.43051 - 28 February 2020

Amended Schedules

R.220 of 2020

Release: 72

G.G.43051 - 28 February 2020

Publishing of Schedules

R.695 of 2019

Release: 71

G.G.42474 - 24 May 2019

Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965

R.696 of 2019

Release: 71

G.G.42474 - 24 May 2019

Exemption of Medical Devices and In-vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Act

R.755 of 2019

Release: 70

G.G.42477 - 23 May 2019

South African Health Regulatory Authority (SAHPRA): Schedules - Amendment

R.756 of 2019

Release: 70

G.G.42477 - 23 May 2019

Exclusion of Certain Preparations containing Cannabidiol (CBD) from Operation of Certain Provisions of the Act

R.685 of 2019

Release: 69

G.G.42465 - 17 May 2019

Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Act

R.27 of 2019

Release: 68

G.G.42183 - 23 January 2019

Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee to be Charged by Persons Licensed in terms of Section 22c (1) (A))

R.28 of 2019

Release: 68

G.G.42183 - 23 January 2019

Regulations relating to a transparent pricing system for medicines and scheduled substances: Dispensing fee for pharmacists

R.29 of 2019

Release: 68

G.G.42183 - 23 January 2019

Annual Single Exit Price Adjustment (SEPA) of medicines and scheduled substances for the year 2019

R.1262 of 2018

Release: 67

G.G.42052 - 23 November 2018

Amendment of Schedules

R.1098 of 2018

Release: 66

G.G.41971 - 12 October 2018

Schedules of Various Substance to Particular Conditions and Inclusion of New Chemical Entities in the Schedules

R.1099 of 2018

Release: 66

G.G.41971 - 12 October 2018

Call Up for Registration of Oral Preparations which Contain a Bacterial Strain(s)

R.1479 of 2017

Release: 65

G.G.41362 - 29 December 2017

Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Amendment

R.1480 of 2017

Release: 65

G.G.41362 - 29 December 2017

Annual Adjustment of the Single Exit Price of Medicines and Schedule Substances (SEPA) for the Year 2018 and Information to be Provided by Manufacturers and or Importers of Medicines and Scheduled Substances

R.1481 of 2017

Release: 65

G.G.41362 - 29 December 2017

Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists

R.1261 of 2017

Release: 64

G.G.41256 - 17 November 2017

Amendment of Schedules

R.1256 of 2017

Release: 64

G.G.41248 - 14 November 2017

Call Up for Registration of Oral Preparations which Contain Bacterial Strains

R.973 of 2017

Release: 63

G.G.41100 - 08 September 2017

Correction Notice

R.859 of 2017

Release: 62

G.G.41064 - 25 August 2017

Medicines and Related Substances Act (101/1965): General regulations made in the Schedule

R.748 of 2017

Release: 61

G.G.41009 - 26 July 2017

Amendment of Schedules

Act 14/2015

Release: 60

G.G.39585 - 08 January 2016

Medicines and Related Substances Amendment Act 14/2015

Act 72/2008

Release: 60

G.G.32148 - 21 April 2009

Medicines and Related Substances Amendment Act 72/2008

R.20 of 2017

Release: 60

G.G.40869 - 26 May 2017

Commencement of Medicines and Related Substances Amendment Act 72/2008

R.157 of 2017

Release: 59

G.G.40637 - 24 February 2017

Notice with regard to Regulations on Medical Devices and In Vitro Diagnostics

R.1589 of 2016

Release: 58

G.G.40515 - 23 February 2017

Amendment: Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances

R.48 of 2017

Release: 58

G.G.40577 - 27 February 2017

Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists

R.1515 of 2016

Release: 57

G.G.40480 - 09 December 2016

Regulations relating to Medical Devices and In Vitro Diagnostic Medical Devices (IVDs)

R.1018 of 2016

Release: 56

G.G.40279 - 16 September 2016

Extension of the Implementation Period of the Interim Adjustment of the Single Exit Price of Medicines and Scheduled Substances (SEPA) for the year 2016

R.565 of 2016

Release: 55

G.G.40015 - 25 May 2016

Exclusion of Certain Medicines from the Operation of Certain Provisions of the Medicines and Related Substance Act, 1965

R.761 of 2016

Release: 54

G.G.40094 - 24 June 2016

Amendment to Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances

R.620 of 2016

Release: 53

G.G.40041 - 23 June 2016

Amendment of Schedules

R.502 of 2016

Release: 52

G.G.39970 - 04 May 2016

Notice with regard to Preparations which Contain Ibogaine

R.25 of 2016

Release: 51

G.G.39594 - 13 January 2016

Information to be Provided by Manufacturers and or Importers of Medicines and Scheduled Substances when Applying for the Single Exit Price Adjustment for 2016

R.352 of 2014

Release: 51

G.G.37622 - 08 May 2014

Schedules: Amendment

R.234 of 2015

Release: 51

G.G.38586 - 20 March 2015

Amendment to the Schedules

R.254 of 2016

Release: 51

G.G.39815 - 15 March 2016

Updating of Schedules on the recommendation of the Medicines Control Council

R.153 of 2016

Release: 50

G.G.39658 - 05 February 2016

Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists

R.784 of 2015

Release: 48

G.G.39154 - 01 September 2015

Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965

R.734 of 2015

Release: 47

G.G.39114 - 19 August 2015

Undesirable Medicine

R.735 of 2015

Release: 47

G.G.39114 - 19 August 2015

Undesirable Medicines

R.739 of 2015

Release: 47

G.G.39121 - 20 August 2015

Undesirable Medicine

R.345 of 2015

Release: 46

G.G.38731 - 23 April 2015

Amendment - Dispensing Fee to be Charged by Persons Licensed in terms of the Medicines and Related Substances Act, 1965

R.211 of 2015

Release: 45

G.G.38566 - 16 March 2015

Regulations relating to the Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists

R.837 of 2014

Release: 43

G.G.38133 - 28 October 2014

Notice with regard to Oral Preparations

R.609 of 2014

Release: 42

G.G.37898 - 07 August 2014

Notice with regard to Undesirable Medicine - Phenyl Butazone

R.104 of 2014

Release: 41

G.G.37318 - 11 February 2014

Amendment to Schedules

R.870 of 2013

Release: 40

G.G.37032 - 15 November 2013

Amendment - General Regulations made in terms of the Medicines and Related Substances Act, 1965

There are no pages referenced by this update

R.766 of 2013

Release: 39

G.G.36929 - 14 October 2013

Amendment to General Regulations as published under R.510 of 2003

There are no pages referenced by this update

R.690 of 2013

Release: 39

G.G.36850 - 20 September 2013

Amendment to Schedules as published under R.935 of 2008 - Updating of the Schedules

R.674 of 2013

Release: 39

G.G.36827 - 13 September 2013

Amendment to Schedules as published under R.935 of 2008 - Updating of the Schedules

R.714 of 2013

Release: 38

G.G.36875 - 26 September 2013

Amendment to R.1102 of 2005 - Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances

R.321 of 2013

Release: 37

G.G.36412 - 25 April 2013

Resolution Approved by the Minister of National Health

R.68 of 2013

Release: 36

G.G.36118 - 01 February 2013

Publication of the Guidelines for Pharmacoeconomic Submissions

R.1026 of 2012

Release: 35

G.G.35947 - 06 December 2012

Disposal of Undesirable Medicine

R.227 of 2012

Release: 33

G.G.35149 - 15 March 2012

Amendment to the Schedules